title: Lipoprotein(a): another emergent target for PCSK9 inhibitors?
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood* / Q000517:prevention & control*; D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL / Q000097:blood*; D006801:Humans; D017270:Lipoprotein(a) / Q000037:antagonists & inhibitors* / Q000097:blood; D000091362:PCSK9 Inhibitors; D011322:Primary Prevention; D055502:Secondary Prevention; D000071449:Proprotein Convertase 9
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D017270:Lipoprotein(a); D000091362:PCSK9 Inhibitors; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9